Mesoblast (NASDAQ:MESO) received a $16.00 price objective from equities researchers at Oppenheimer in a research note issued to investors on Tuesday, November 14th. The brokerage currently has a “buy” rating on the stock. Oppenheimer’s price objective points to a potential upside of 209.48% from the company’s previous close. Oppenheimer also issued estimates for Mesoblast’s Q2 2018 earnings at ($0.19) EPS, Q3 2018 earnings at ($0.19) EPS, Q4 2018 earnings at ($0.19) EPS, FY2018 earnings at ($0.76) EPS, Q1 2019 earnings at ($0.19) EPS, Q2 2019 earnings at ($0.20) EPS, Q3 2019 earnings at ($0.21) EPS, Q4 2019 earnings at $0.06 EPS and FY2019 earnings at ($0.54) EPS.
Several other research firms have also recently commented on MESO. Credit Suisse Group set a $11.00 price target on shares of Mesoblast and gave the stock a “hold” rating in a report on Tuesday, July 18th. BidaskClub lowered shares of Mesoblast from a “sell” rating to a “strong sell” rating in a research report on Friday, July 28th. Maxim Group set a $14.00 price target on shares of Mesoblast and gave the company a “buy” rating in a research report on Wednesday, August 16th. Cantor Fitzgerald set a $20.00 price objective on shares of Mesoblast and gave the stock a “buy” rating in a report on Wednesday, August 16th. Finally, CIBC started coverage on shares of Mesoblast in a research note on Thursday, August 31st. They set an “outperform” rating and a $16.00 price objective for the company. Three investment analysts have rated the stock with a sell rating, two have assigned a hold rating and four have assigned a buy rating to the company. Mesoblast presently has an average rating of “Hold” and a consensus target price of $13.14.
Shares of Mesoblast (NASDAQ MESO) traded down $0.05 on Tuesday, hitting $5.17. The stock had a trading volume of 16,604 shares, compared to its average volume of 28,247. Mesoblast has a 12 month low of $4.39 and a 12 month high of $12.50.
COPYRIGHT VIOLATION WARNING: This piece was reported by BBNS and is owned by of BBNS. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of U.S. and international copyright & trademark laws. The legal version of this piece can be read at https://baseballnewssource.com/markets/mesoblast-limited-meso-pt-set-at-16-00-by-oppenheimer-holdings-inc/1783024.html.
Receive News & Ratings for Mesoblast Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast Limited and related companies with our FREE daily email newsletter.